Teva ADR earnings, Revenue beat in Q4

  • Investing.com
Teva ADR earnings, Revenue beat in Q4

Investing.com - Teva ADR reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Teva ADR announced earnings per share of $0.68 on revenue of $4.5B. Analysts polled by Investing.com anticipated EPS of $0.626 on revenue of $4.36B.

Teva ADR shares are up 32.85% from the beginning of the year and are trading at $12.82 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% year to date.

Teva ADR follows other major Healthcare sector earnings this month

Teva ADR's report follows an earnings beat by J&J on Tuesday, January 26, 2021, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Roche Holding ADR had missed expectations on Monday, February 1, 2021 with fourth quarter EPS of $1.21 on revenue of $15.88B, compared to forecast for EPS of $1.28 on revenue of $16.45B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles